Del M. Lopez-Noblejas

Ciudad Real, CM 13071, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.

Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.

Journal: Journal of medicinal chemistry
Published: April 06, 2026

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Journal: Current treatment options in oncology
Published: January 21, 2026

Dual-drug codelivery gelatin-based hydrogel of ARV-471 and Palbociclib enhances synergistic effect in breast cancer treatment.

Dual-drug codelivery gelatin-based hydrogel of ARV-471 and Palbociclib enhances synergistic effect in breast cancer treatment.

Journal: Scientific reports
Published: September 26, 2025

Tuna Collagen-Based hydrogels for the targeted delivery of BET inhibitors and BET-PROTACs in breast cancer therapy.

Tuna Collagen-Based hydrogels for the targeted delivery of BET inhibitors and BET-PROTACs in breast cancer therapy.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: June 18, 2025

Liposomal formulation of the CDK9 PROTAC THAL-SNS-032 enhances the antitumor activity in breast cancer cell lines.

Liposomal formulation of the CDK9 PROTAC THAL-SNS-032 enhances the antitumor activity in breast cancer cell lines.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 10, 2025

TACkling Cancer by Targeting Selective Protein Degradation.

TACkling Cancer by Targeting Selective Protein Degradation.

Journal: Pharmaceutics
Published: September 04, 2023

T-reg transcriptomic signatures identify response to check-point inhibitors.

T-reg transcriptomic signatures identify response to check-point inhibitors.

Journal: Scientific reports
Published: July 19, 2023

Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers.

Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers.

Journal: Cancers
Published: July 31, 2022

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

Journal: International journal of molecular sciences
Published: April 14, 2022

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles.

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles.

Journal: Frontiers in cell and developmental biology
Published: October 30, 2021

Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer.

Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer.

Journal: Cancers
Published: July 19, 2021

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

Journal: International journal of molecular sciences
Published: February 18, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026